NOT KNOWN DETAILS ABOUT PONSEGROMAB

Identify appropriate candidates for remdesivir therapy according to clinical conditions, for instance critical COVID-19 infection and particular client characteristics.The FDA acceptance was dependant on period 1 and period three REDPINE trials, which showed the pharmacokinetics and safety profile from the drug in patients with intense renal impair